McMaster Immunology Research Centre, M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Mucosal Immunol. 2012 Jul;5(4):420-31. doi: 10.1038/mi.2012.19. Epub 2012 Mar 28.
The immune mechanisms underlying unsatisfactory pulmonary mucosal protection by parenteral Bacillus Calmette-Guérin (BCG) immunization remain poorly understood. We found that parenteral BCG immunization failed to elicit airway luminal T cells (ALT) whereas it induced significant T cells in the lung interstitium. After Mycobacterium tuberculosis (M.tb) challenge, ALT remained missing for 10 days. The lack of ALT correlated with lack of lung protection for 14 days post-M.tb challenge. To further investigate the role of ALT, ALT were elicited in BCG-immunized animals by intranasal inoculation of M.tb culture-filtrate (CF) proteins. Installment of ALT by CF restored protection in the early phases of M.tb infection, which was linked to rapid increases in ALT, but not in lung interstitial T cells. Also, adoptive transfer of T cells to the airway lumen of BCG-immunized animals also accelerated protection. This study thus provides novel evidence that unsatisfactory lung protection by parenteral BCG immunization is due to delayed ALT recruitment after pulmonary M.tb exposure.
BCG 疫苗经肺部黏膜给药后的免疫机制尚不完全清楚,我们发现其不能诱导气道腔中的 T 细胞(ALT),而只能在肺部间质中诱导显著的 T 细胞。在结核分枝杆菌(M.tb)攻击后,10 天内 ALT 仍然缺失。这种 ALT 的缺乏与 M.tb 攻击后 14 天内肺保护的缺乏有关。为了进一步研究 ALT 的作用,我们通过鼻腔接种 M.tb 培养滤液(CF)蛋白来诱导 BCG 免疫动物中的 ALT。CF 诱导的 ALT 恢复了 M.tb 感染早期阶段的保护作用,这与 ALT 的快速增加有关,而与肺间质 T 细胞无关。此外,将 T 细胞过继转移到 BCG 免疫动物的气道腔中也能加速保护作用。因此,这项研究提供了新的证据,表明经肺部黏膜给药的 BCG 免疫后肺部保护作用不理想,是由于肺部 M.tb 暴露后 ALT 的募集延迟所致。